A detailed history of Invictus Private Wealth, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Invictus Private Wealth, LLC holds 3,363 shares of DXCM stock, worth $215,232. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,363
Previous 3,500 3.91%
Holding current value
$215,232
Previous $434 Million 7.4%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$114.22 - $140.1 $15,648 - $19,193
-137 Reduced 3.91%
3,363 $466 Million
Q4 2023

Feb 12, 2024

SELL
$75.49 - $124.16 $11,172 - $18,375
-148 Reduced 4.06%
3,500 $434 Million
Q3 2023

Oct 04, 2023

SELL
$86.06 - $137.93 $172 - $275
-2 Reduced 0.05%
3,648 $340 Million
Q4 2022

Jun 05, 2023

BUY
$84.98 - $122.67 $310,177 - $447,745
3,650 New
3,650 $413 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $24.7B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Invictus Private Wealth, LLC Portfolio

Follow Invictus Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invictus Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invictus Private Wealth, LLC with notifications on news.